Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease

被引:7
|
作者
Jia, Jue [1 ]
Liu, Ruoshuang [1 ]
Wei, Weiping [1 ]
Yu, Fan [2 ]
Yu, Xiawen [1 ]
Shen, Yirong [1 ]
Chen, Caiqin [1 ]
Cai, Zhensheng [1 ]
Wang, Chenxi [1 ]
Zhao, Zhicong [1 ]
Wang, Dong [1 ]
Yang, Ling [1 ]
Yuan, Guoyue [1 ]
机构
[1] Jiangsu Univ, Dept Endocrinol & Metab, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China
[2] Jiangsu Univ, Dept Endocrinol & Metab, Jurong Hosp, Zhenjiang, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
monocyte to high-density lipoprotein cholesterol ratio (MHR); metabolic-associated fatty liver disease; type 2 diabetes mellitus; inflammatory marker; obesity; INSULIN-RESISTANCE; INFLAMMATION; SEVERITY;
D O I
10.3389/fphys.2021.762242
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Recently, monocyte to high-density lipoprotein cholesterol ratio (MHR) as a novel inflammatory biomarker has drawn lots of attention. This study was conducted in patients with type 2 diabetes mellitus (T2DM) to investigate the correlation between MHR and metabolic-associated fatty liver disease (MAFLD).Methods: Totally, 1,051 patients with T2DM from the Affiliated Hospital of Jiangsu University were enrolled and classified as MAFLD (n = 745) group and non-MAFLD (n = 306) group according to the MAFLD diagnostic criteria. In contrast, patients were also separated into four groups based on MHR quartiles. Anthropometric and biochemical measurements were performed. The visceral fat area (VFA) and subcutaneous fat area (SFA) of participants were measured by dual bioelectrical impedance. Fatty liver was assessed by ultrasonography.Results: The MHR level of subjects in the MAFLD group was statistically greater than that in the non-MAFLD group (P < 0.05). Meanwhile, MHR was higher in the overweight or obese MAFLD group compared with that in the lean MAFLD group (P < 0.05). The area under the ROC Curve (AUC) assessed by MHR was larger than that of other inflammatory markers (P < 0.01). The cutoff value of MHR was 0.388, with a sensitivity of 61.74% and a specificity of 56.54%. For further study, binary logistic regression analyses of MAFLD as a dependent variable, the relationship between MHR and MAFLD was significant (P < 0.01). After adjusting for many factors, the relationship still existed. In the four groups based on MHR quartiles, groups with higher values of MHR had a significantly higher prevalence of MAFLD (P < 0.05). The percentage of patients with obese MAFLD increased as the MHR level increased (P < 0.01). Among different quartiles of MHR, it showed that with the increasing of MHR, the percentage of patients with MAFLD who had more than four metabolic dysfunction indicators increased, which was 46.39, 60.52, 66.79, and 79.91%, respectively, in each quartile.Conclusion: Monocyte to high-density lipoprotein cholesterol ratio is a simple and practicable inflammatory parameter that could be used for assessing MAFLD in T2DM. T2DM patients with higher MHR have more possibility to be diagnosed as MAFLD. Therefore, more attention should be given to the indicator in the examination of T2DM.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study
    Zhi Liu
    He He
    Yuzhao Dai
    Lidan Yang
    Shenling Liao
    Zhenmei An
    Shuangqing Li
    [J]. Lipids in Health and Disease, 21
  • [32] Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus
    Tan, Hong Chang
    Tai, E. Shyong
    Sviridov, Dmitri
    Nestel, Paul J.
    Ng, Cindy
    Chan, Edmund
    Teo, Yvonne
    Wai, Daniel Chun Hang
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (06) : 467 - 473
  • [33] Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol
    Juren, Andrew J.
    Sarwal, Gautamn
    Al-Sarraf, Ahmad
    Vrablik, Michal
    Chan, Darren
    Humphries, Karin H.
    Frohlich, Jiri J.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (03) : 194 - 198
  • [34] Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
    Lee, Sejeong
    Bae, Jaehyun
    Jo, Doo Ri
    Lee, Minyoung
    Lee, Yong-ho
    Kang, Eun Seok
    Cha, Bong-Soo
    Lee, Byung-Wan
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [35] The correlation of triglyceride/high-density lipoprotein cholesterol ratio with muscle mass in type 2 diabetes patients
    Qingsong Fu
    Zhenwen Zhang
    Wenchao Hu
    Yinrong Yang
    [J]. BMC Endocrine Disorders, 23
  • [36] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIABETES-MELLITUS
    MATEOS, JMG
    DIAZ, JP
    [J]. REVISTA CLINICA ESPANOLA, 1983, 170 (3-4): : 107 - 113
  • [37] The correlation of triglyceride/high-density lipoprotein cholesterol ratio with muscle mass in type 2 diabetes patients
    Fu, Qingsong
    Zhang, Zhenwen
    Hu, Wenchao
    Yang, Yinrong
    [J]. BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [38] Association between ketogenic capacity and metabolic-associated fatty liver disease in patients with type 2 diabetes
    Bae, J.
    Lee, S.
    Lee, M.
    Lee, Y. -H.
    Kang, E. S.
    Cha, B. -S.
    Lee, B. -W.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S506 - S506
  • [39] Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus
    Canpolat, Asena Gokcay
    Emral, Rifat
    Keskin, Caglar
    Canlar, Sule
    Sahin, Mustafa
    Corapcioglu, Demet
    [J]. BIOMARKERS IN MEDICINE, 2019, 13 (11) : 907 - 915
  • [40] The correlation between visceral fat/subcutaneous fat area ratio and monocyte/high-density lipoprotein ratio in patients with type 2 diabetes mellitus and albuminuria
    Lin, Haiyan
    Zhu, Jun
    Zheng, Chen
    Xu, Xiaoming
    Ye, Shandong
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (11)